Gujarat-based manufacturer of medical equipment Sahajanand Medical Technologies (SMT) has raised Rs. 150 crore from Samara Capital Partners.
|Deal||Samara Capital Partners invests in SMT|
|Deal Type||Private Equity|
|Law Firms||Lakshmikumaran & Sridharan – SMT; Economic Laws Practice – Samara Capital|
|Partners/Heads||Lakshmikumaran & Sridharan – Sudish Sharma; Economic Laws Practice – Darshan Upadhyay|
Lakshmikumaran & Sridharan acted for SMT, through a team led by Executive Partner Sudish Sharma, Principal Associate Vatsal Gaur, and Associate Aman Parnami.
Economic Laws Practice represented Samara Capital on the deal, with a team led by Partner Darshan Upadhyay, Joint Partner Amit Manubarwala and Associate Dhairal Shah.
SMT is a leading manufacturer of coronary stents. Market reports estimate India’s coronary stent market to reach nearly USD 531 million in revenues by end of 2016 and grow rapidly at 14% CAGR.
This investment shall boost SMT’s R&D efforts at offering cutting-edge cardiovascular medical devices and facilitating SMT’s entry into competitive global markets, including US, Western Europe and Japan.
With a premium account you get:
- One year of unrestrcited access to previous interviews, columns and articles
- One year access to all archival material
- Access to all Bar & Bench reports
Already a subscriber ?